| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.52B | -1.0% |
| Cost of Revenue | $1.36B | -0.3% |
| R&D Expense | $8.8M | -10.2% |
| SG&A Expense | $94.0M | -1.6% |
| Pre-tax Income | $45.6M | -34.2% |
| Income Tax | $1.4M | -90.2% |
| Net Income | $44.1M | -19.2% |
| EPS (Basic) | $1.65 | -17.5% |
| EPS (Diluted) | $1.62 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.6M | -34.3% |
| Inventory | $212.4M | +0.3% |
| Current Assets | $387.1M | -7.8% |
| Total Assets | $1.59B | +6.6% |
| Current Liabilities | $357.1M | -0.5% |
| Total Liabilities | $820.3M | +8.4% |
| Stockholders' Equity | $774.6M | +4.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $135.4M | +15.2% |
| Capital Expenditures | $133.7M | +24.5% |
| Investing Cash Flow | -$142.9M | -28.9% |
| Financing Cash Flow | -$2.7M | +65.5% |
| Free Cash Flow | $1.7M | -83.4% |
| -16.9% |